Lack of Association between Poor Glycemic Control in T2DM and Subclinical Hypothyroidism.

IF 1.7 Q4 ENDOCRINOLOGY & METABOLISM
Journal of Thyroid Research Pub Date : 2020-09-08 eCollection Date: 2020-01-01 DOI:10.1155/2020/8121395
Pragya Sharma, Rashmi Sinha, Anupa Prasad, J K Mitra
{"title":"Lack of Association between Poor Glycemic Control in T2DM and Subclinical Hypothyroidism.","authors":"Pragya Sharma,&nbsp;Rashmi Sinha,&nbsp;Anupa Prasad,&nbsp;J K Mitra","doi":"10.1155/2020/8121395","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hypothyroidism is a highly prevalent and multifactorial disorder and has been implicated in the causation of dyslipidemia, dermatological diseases, atherosclerosis, and myocardial dysfunction, as well as endothelial dysfunction. The relationship between subclinical hypothyroidism and type 2 diabetes mellitus is not well established. In the present study, we attempt to find out the prevalence of subclinical hypothyroidism in type 2 diabetes mellitus and its association with glycemic control.</p><p><strong>Materials and methods: </strong>This was an observational study in which 205 consecutive patients of T2DM visiting the outpatient department of medicine were recruited. Serum TSH, free thyroxine, free triiodothyronine, and lipid profile, as well as HbA1c assays, were done in the study participants, and they were categorized into three groups by HbA1c: <7%, 7-9%, and >9%.</p><p><strong>Results: </strong>There is a high prevalence of subclinical hypothyroidism in type 2 DM patients. Mean HbA1c in diabetics without SCH was 7.89%, whereas it was 8.33% in diabetics with SCH. This difference was statistically not significant. TSH was not found to be significantly associated with HbA1c.</p><p><strong>Conclusion: </strong>High prevalence of SCH in T2DM patients suggests that there is a need for regular follow-up to check the progression of SCH to overt hypothyroidism. High serum TSH is not a predictor of poor glycemic control.</p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2020 ","pages":"8121395"},"PeriodicalIF":1.7000,"publicationDate":"2020-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/8121395","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Thyroid Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2020/8121395","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 4

Abstract

Background: Hypothyroidism is a highly prevalent and multifactorial disorder and has been implicated in the causation of dyslipidemia, dermatological diseases, atherosclerosis, and myocardial dysfunction, as well as endothelial dysfunction. The relationship between subclinical hypothyroidism and type 2 diabetes mellitus is not well established. In the present study, we attempt to find out the prevalence of subclinical hypothyroidism in type 2 diabetes mellitus and its association with glycemic control.

Materials and methods: This was an observational study in which 205 consecutive patients of T2DM visiting the outpatient department of medicine were recruited. Serum TSH, free thyroxine, free triiodothyronine, and lipid profile, as well as HbA1c assays, were done in the study participants, and they were categorized into three groups by HbA1c: <7%, 7-9%, and >9%.

Results: There is a high prevalence of subclinical hypothyroidism in type 2 DM patients. Mean HbA1c in diabetics without SCH was 7.89%, whereas it was 8.33% in diabetics with SCH. This difference was statistically not significant. TSH was not found to be significantly associated with HbA1c.

Conclusion: High prevalence of SCH in T2DM patients suggests that there is a need for regular follow-up to check the progression of SCH to overt hypothyroidism. High serum TSH is not a predictor of poor glycemic control.

Abstract Image

Abstract Image

T2DM患者血糖控制不良与亚临床甲状腺功能减退之间缺乏相关性。
背景:甲状腺功能减退是一种非常普遍的多因素疾病,与血脂异常、皮肤病、动脉粥样硬化、心肌功能障碍以及内皮功能障碍有关。亚临床甲状腺功能减退与2型糖尿病的关系尚不明确。在本研究中,我们试图了解亚临床甲状腺功能减退症在2型糖尿病患者中的患病率及其与血糖控制的关系。材料和方法:这是一项观察性研究,招募了205例连续就诊门诊的2型糖尿病患者。在研究参与者中进行了血清TSH、游离甲状腺素、游离三碘甲状腺原氨酸、血脂和HbA1c检测,并根据HbA1c分为三组:9%。结果:2型糖尿病患者中亚临床甲状腺功能减退的发生率较高。糖尿病非SCH组平均HbA1c为7.89%,糖尿病合并SCH组平均HbA1c为8.33%,差异无统计学意义。未发现TSH与HbA1c显著相关。结论:T2DM患者中SCH的高患病率提示有必要定期随访,检查SCH是否发展为明显的甲状腺功能减退。高血清TSH并不是血糖控制不良的预测指标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Thyroid Research
Journal of Thyroid Research ENDOCRINOLOGY & METABOLISM-
CiteScore
4.40
自引率
0.00%
发文量
10
审稿时长
17 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信